You have access
Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer
AKIHIRO TSUKAGUCHI, AKIHIRO TAMIYA, SHOICHI FUKUDA, YUKI IWAHASHI, KENSUKE KANAOKA, YUYA TANAKA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, TOMOKO KAGAWA, YOSHINOBU MATSUDA and KYOICHI OKISHIO
Anticancer Research October 2024, 44 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.17280
